L’edici\u00f3 gen\u00e8tica ha avan\u00e7at els darrers anys, amb tecnologies com el CRISPR-Cas9, que permeten modificar l’ADN amb una precisi\u00f3 molt avan\u00e7ada. Aquest progr\u00e9s dona oportunitats a tractaments revolucionaris per a malalties gen\u00e8tiques.<\/p>\n
\ud83e\uddec CRISPR i el seu Potencial Terap\u00e8utic<\/strong><\/p>\n CRISPR-Cas9, actua com un bistur\u00ed molecular per poder tallar i corregir gens defectuosos. Ara mateix, s\u2019est\u00e0 investigant la seva aplicaci\u00f3 a:<\/p>\n Malalties heredit\u00e0ries:<\/strong> Com a fibrosi qu\u00edstica, an\u00e8mia falciforme i distr\u00f2fia muscular de Duchanne. \ud83c\udfe5 Assajos Cl\u00ednics i Primers Resultats<\/strong><\/p>\n El primer tractament basat en CRISPR per l\u2019an\u00e8mia falciforme va ser aprovat el 2023 per FDA. I altres assaigs han demostrat aven\u00e7os prometedors a la correcci\u00f3 de les mutacions gen\u00e8tiques dolentes.<\/p>\n \u00c8tica i Desafiaments<\/strong> El futur de l\u2019Edici\u00f3 Gen\u00e8tica<\/strong> L’edici\u00f3 gen\u00e8tica ha avan\u00e7at els darrers anys, amb tecnologies com el CRISPR-Cas9, que permeten modificar l’ADN amb una precisi\u00f3 molt avan\u00e7ada. Aquest progr\u00e9s dona oportunitats a tractaments revolucionaris per a malalties gen\u00e8tiques. \ud83e\uddec CRISPR i el seu Potencial Terap\u00e8utic CRISPR-Cas9, actua com un bistur\u00ed molecular per poder tallar i corregir gens defectuosos. Ara mateix, s\u2019est\u00e0 […]<\/p>\n","protected":false},"author":1331,"featured_media":25401,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[136,102],"tags":[],"class_list":["post-25043","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies","category-revista"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/25043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/users\/1331"}],"replies":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/comments?post=25043"}],"version-history":[{"count":5,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/25043\/revisions"}],"predecessor-version":[{"id":25439,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/25043\/revisions\/25439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/media\/25401"}],"wp:attachment":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/media?parent=25043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/categories?post=25043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/tags?post=25043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nC\u00e0ncer:<\/strong> S\u2019estan provant ter\u00e0pies que modifiquen c\u00e8l\u00b7lules immunit\u00e0ries per atacar tumors de manera m\u00e9s efica\u00e7
\nVIH:<\/strong> S\u2019han fet estudis en qu\u00e8 s\u2019eliminen seq\u00fc\u00e8ncies del virus en c\u00e8l\u00b7lules infectades.<\/p>\n
\nL\u2019edici\u00f3 gen\u00e8tica t\u00e9 un potencial bastant gran, tamb\u00e9 dona dilemes \u00e8tics. La possibilitat de modificar embrions humans ha generat debats sobre les implicacions morals i socials.<\/p>\n
\nAmb noves eines com CRISPR 2.0 (molt m\u00e9s precisa i segura) i l\u2019edici\u00f3 epigen\u00e8tica (que no altera directament l\u2019ADN), s\u2019espera que durant la d\u00e8cada vinent moltes malalties abans incurables es puguin tractar de manera efectiva.<\/p>\n","protected":false},"excerpt":{"rendered":"